ASX · Financial Statements

Arovella Therapeutics Limited (ALA.AX) Financial Statements

$0.05 ASX: ALA.AX Market Cap $73.74M

Full income statement, balance sheet, and cash flow statement for Arovella Therapeutics Limited (ALA.AX), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-7.81
FCF Yield—
Quick Ratio17.27
Interest Coverage—
Return 1Y-44.21%
Return 3Y-30.26%
Return 5Y12.77%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
ALA.AX Overview ALA.AX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.